23.5 C
New York
Thursday, July 3, 2025

Tag: investment strategy

Addentax Group Corp. Enters Into US$1.3 Billion Term Sheet for Proposed Acquisition of Up to 12,000 Bitcoins

SHENZHEN, China, July 2, 2025 /PRNewswire/ -- Addentax Group Corp. (Nasdaq: ATXG) (the "Company") today announced that it has entered into a non-binding term...

EV Tax Credit Termination Post-September—Evaluating Implications for Investment Strategy

The recent passage of a tax-and-spending package, supported by President Trump and narrowly approved by the Senate, has significant implications for the electric vehicle...

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of June 30,...

HOUSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2025.

Novo Holdings portfolio company Kate Farms acquired by Danone

Novo Holdings led Kate Farms' Series C financing in 2022 and supported its continued growth as the company's largest institutional investor Transaction highlights the Planetary...

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy

CAMBRIDGE, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, PROMINENT. The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to tacrolimus in adults diagnosed with primary membranous nephropathy (PMN). PROMINENT is designed to enroll approximately 180 adults with PMN and expected to readout in 2029. PMN is a severe antibody-mediated disease of the kidney that is a leading cause of nephrotic syndrome and carries a significant risk of kidney failure.

E-L Financial Corporation Limited Enters Into Automatic Share Purchase Plan

TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- E-L Financial Corporation Limited (TSX:ELF) (TSX:ELF.PR.F) (TSX:ELF.PR.G) (TSX:ELF.PR.H) (the “Company”) announced today that, as part of its previously announced normal course issuer bid (the “Bid”), it has entered into a pre-defined automatic share purchase plan (“ASPP”) with its designated broker in order to facilitate repurchases of the Company’s common shares (the “Shares”). The ASPP has received clearance from the Toronto Stock Exchange (the “Exchange”) and is scheduled to take effect on June 30, 2025.

China Dongxiang Announces FY2024/25 Annual Results

Stabilisation and Recovery in China Sporting Goods Business Dual-business Synergy Fuels High-Quality Development of China Dongxiang Results Highlights Revenue amounted to RMB1,680 million, representing a decrease of 3.7% year-on-year...

PHOENIX INVESTORS ACQUIRES 1.5 MILLION-SQUARE-FOOT INDUSTRIAL COMPLEX IN CORSICANA, TX

Strategically located facility ideal for distribution and warehousing CORSICANA, Texas, June 25, 2025 /PRNewswire/ -- An affiliate of Phoenix Investors ("Phoenix") announced the acquisition of...

Lakeland Capital Welcomes 2025 Summer Interns

CHARLESTON, S.C., June 25, 2025 (GLOBE NEWSWIRE) -- Lakeland Capital, a Charleston-based private, multifamily investment company active in select East Coast markets, is pleased to welcome Margaret Cover and Michael Smyth to its 2025 summer intern class.

Strategic Annuity Acquisition: Four Key Steps for Financial Executives

Establishing a reliable income stream through an immediate annuity requires a methodical approach to ensure financial security and longevity of returns. By adhering to...

TVM Capital Healthcare Appoints Dr. Su-Lin Chong in Malaysia as Investment Committee Member and Operating Partner

SINGAPORE, June 25, 2025 /PRNewswire/ -- TVM Capital Healthcare, a leading international healthcare private equity firm and operator focused on emerging markets, announces the appointment...

TVM Capital Healthcare Appoints Dr. Su-Lin Chong in Malaysia as Investment Committee Member and Operating Partner

SINGAPORE, June 25, 2025 /PRNewswire/ -- TVM Capital Healthcare, a leading international healthcare private equity firm and operator focused on emerging markets, announces the appointment...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInvestment strategy